These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 36498995)

  • 1. Regulation of P-Glycoprotein in the Brain.
    Chai AB; Callaghan R; Gelissen IC
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier.
    Cisternino S; Mercier C; Bourasset F; Roux F; Scherrmann JM
    Cancer Res; 2004 May; 64(9):3296-301. PubMed ID: 15126373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening novel CNS drug candidates for P-glycoprotein interactions using the cell line iP-gp: In vitro efflux ratios from iP-gp and MDCK-MDR1 monolayers compared to brain distribution data from mice.
    Ozgür B; Saaby L; Janfelt C; Langthaler K; Eneberg E; Jacobsen AM; Badolo L; Montanari D; Brodin B
    Eur J Pharm Biopharm; 2021 Dec; 169():211-219. PubMed ID: 34756975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of juvenile and adult blood-brain barrier to endothelin-1: regulation of P-glycoprotein and breast cancer resistance protein expression and transport activity.
    Harati R; Villégier AS; Banks WA; Mabondzo A
    J Neuroinflammation; 2012 Dec; 9():273. PubMed ID: 23253775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of P-glycoprotein and Breast Cancer Resistance Protein Expression Induced by Focused Ultrasound-Mediated Blood-Brain Barrier Disruption: A Pilot Study.
    Conti A; Geffroy F; Kamimura HAS; Novell A; Tournier N; Mériaux S; Larrat B
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of P-glycoprotein and multidrug resistance associated protein 1 in the transport of tanshinone IIB, a primary active diterpenoid quinone from the roots of Salvia miltiorrhiza, across the blood-brain barrier.
    Zhou ZW; Chen X; Liang J; Yu XY; Wen JY; Zhou SF
    Drug Metab Lett; 2007 Aug; 1(3):205-17. PubMed ID: 19356045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging the impact of blood-brain barrier disruption induced by focused ultrasound on P-glycoprotein function.
    Goutal S; Novell A; Leterrier S; Breuil L; Selingue E; Gerstenmayer M; Marie S; Saubaméa B; Caillé F; Langer O; Truillet C; Larrat B; Tournier N
    J Control Release; 2023 Sep; 361():483-492. PubMed ID: 37562557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saturable active efflux by p-glycoprotein and breast cancer resistance protein at the blood-brain barrier leads to nonlinear distribution of elacridar to the central nervous system.
    Sane R; Agarwal S; Mittapalli RK; Elmquist WF
    J Pharmacol Exp Ther; 2013 Apr; 345(1):111-24. PubMed ID: 23397054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in dipole membrane potential at the mouse blood-brain barrier enhance the transport of 99mTechnetium Sestamibi more than inhibiting Abcb1, Abcc1, or Abcg2.
    Cattelotte J; Tournier N; Rizzo-Padoin N; Schinkel AH; Scherrmann JM; Cisternino S
    J Neurochem; 2009 Feb; 108(3):767-75. PubMed ID: 19067785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential Regulation Mechanisms of P-gp in the Blood-Brain Barrier in Hypoxia.
    Ding Y; Wang R; Zhang J; Zhao A; Lu H; Li W; Wang C; Yuan X
    Curr Pharm Des; 2019; 25(10):1041-1051. PubMed ID: 31187705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efavirenz does not interact with the ABCB1 transporter at the blood-brain barrier.
    Dirson G; Fernandez C; Hindlet P; Roux F; German-Fattal M; Gimenez F; Farinotti R
    Pharm Res; 2006 Jul; 23(7):1525-32. PubMed ID: 16779703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the efflux transporter, P-glycoprotein, at the blood-brain barrier in drug discovery.
    Cox B; Nicolaï J; Williamson B
    Biopharm Drug Dispos; 2023 Feb; 44(1):113-126. PubMed ID: 36198662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier.
    Narang VS; Fraga C; Kumar N; Shen J; Throm S; Stewart CF; Waters CM
    Am J Physiol Cell Physiol; 2008 Aug; 295(2):C440-50. PubMed ID: 18524938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of BCRP (ABCG2) and P-glycoprotein (ABCB1) by cytokines in a model of the human blood-brain barrier.
    Poller B; Drewe J; Krähenbühl S; Huwyler J; Gutmann H
    Cell Mol Neurobiol; 2010 Jan; 30(1):63-70. PubMed ID: 19629677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An electrically tight in vitro blood-brain barrier model displays net brain-to-blood efflux of substrates for the ABC transporters, P-gp, Bcrp and Mrp-1.
    Helms HC; Hersom M; Kuhlmann LB; Badolo L; Nielsen CU; Brodin B
    AAPS J; 2014 Sep; 16(5):1046-55. PubMed ID: 24934296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Borneol Depresses P-Glycoprotein Function by a NF-κB Signaling Mediated Mechanism in a Blood Brain Barrier in Vitro Model.
    Fan X; Chai L; Zhang H; Wang Y; Zhang B; Gao X
    Int J Mol Sci; 2015 Nov; 16(11):27576-88. PubMed ID: 26593909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper bis(thiosemicarbazone) complexes modulate P-glycoprotein expression and function in human brain microvascular endothelial cells.
    Pyun J; McInnes LE; Donnelly PS; Mawal C; Bush AI; Short JL; Nicolazzo JA
    J Neurochem; 2022 Aug; 162(3):226-244. PubMed ID: 35304760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of P-Glycoprotein-Mediated Drug-Endogenous Substrate Interactions on Androgen and Blood-Brain Barrier Permeability.
    Sunakawa H; Mizoi K; Takahashi R; Takahashi S; Ogihara T
    J Pharm Sci; 2024 Jan; 113(1):228-234. PubMed ID: 37898165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P-glycoprotein mediated efflux limits the transport of the novel anti-Parkinson's disease candidate drug FLZ across the physiological and PD pathological in vitro BBB models.
    Liu Q; Hou J; Chen X; Liu G; Zhang D; Sun H; Zhang J
    PLoS One; 2014; 9(7):e102442. PubMed ID: 25036090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astrocyte-mediated regulation of multidrug resistance p-glycoprotein in fetal and neonatal brain endothelial cells: age-dependent effects.
    Baello S; Iqbal M; Gibb W; Matthews SG
    Physiol Rep; 2016 Aug; 4(16):. PubMed ID: 27796269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.